Quantbot Technologies LP Decreases Stock Position in Cardinal Health, Inc. (NYSE:CAH)

Quantbot Technologies LP lowered its holdings in shares of Cardinal Health, Inc. (NYSE:CAH - Free Report) by 17.4% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 76,445 shares of the company's stock after selling 16,061 shares during the period. Quantbot Technologies LP's holdings in Cardinal Health were worth $9,041,000 at the end of the most recent quarter.

Several other large investors have also added to or reduced their stakes in the business. MRP Capital Investments LLC grew its stake in Cardinal Health by 3.0% in the fourth quarter. MRP Capital Investments LLC now owns 5,140 shares of the company's stock valued at $608,000 after acquiring an additional 150 shares during the period. 1620 Investment Advisors Inc. grew its stake in Cardinal Health by 4.9% in the fourth quarter. 1620 Investment Advisors Inc. now owns 3,205 shares of the company's stock valued at $379,000 after acquiring an additional 149 shares during the period. Wayfinding Financial LLC acquired a new stake in Cardinal Health in the fourth quarter valued at approximately $236,000. Lee Danner & Bass Inc. acquired a new stake in Cardinal Health in the fourth quarter valued at approximately $35,000. Finally, Whittier Trust Co. grew its stake in Cardinal Health by 30.7% in the fourth quarter. Whittier Trust Co. now owns 1,729 shares of the company's stock valued at $204,000 after acquiring an additional 406 shares during the period. Institutional investors and hedge funds own 87.17% of the company's stock.

Cardinal Health Stock Up 1.0 %

Cardinal Health stock traded up $1.33 during mid-day trading on Tuesday, reaching $131.36. 1,529,595 shares of the company's stock were exchanged, compared to its average volume of 1,976,591. The business's fifty day simple moving average is $126.54 and its 200 day simple moving average is $119.56. The firm has a market capitalization of $31.73 billion, a PE ratio of 24.51, a P/E/G ratio of 1.49 and a beta of 0.66. Cardinal Health, Inc. has a one year low of $93.17 and a one year high of $132.84.

Remove Ads

Cardinal Health (NYSE:CAH - Get Free Report) last issued its quarterly earnings results on Thursday, January 30th. The company reported $1.93 EPS for the quarter, topping analysts' consensus estimates of $1.74 by $0.19. Cardinal Health had a negative return on equity of 59.57% and a net margin of 0.59%. On average, sell-side analysts forecast that Cardinal Health, Inc. will post 7.95 earnings per share for the current year.

Cardinal Health Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, April 15th. Shareholders of record on Tuesday, April 1st will be given a $0.5056 dividend. This represents a $2.02 dividend on an annualized basis and a yield of 1.54%. The ex-dividend date is Tuesday, April 1st. Cardinal Health's dividend payout ratio is currently 37.69%.

Analysts Set New Price Targets

A number of equities research analysts have commented on CAH shares. Wells Fargo & Company raised their price objective on Cardinal Health from $135.00 to $136.00 and gave the company an "equal weight" rating in a research note on Tuesday, February 4th. Argus set a $148.00 price objective on Cardinal Health in a research note on Tuesday, February 4th. Jefferies Financial Group raised Cardinal Health from a "hold" rating to a "buy" rating and raised their price objective for the company from $140.00 to $150.00 in a research note on Wednesday, February 5th. TD Cowen upgraded Cardinal Health from a "hold" rating to a "buy" rating and raised their target price for the company from $130.00 to $144.00 in a report on Wednesday, January 8th. Finally, Mizuho started coverage on Cardinal Health in a report on Wednesday, December 4th. They issued an "outperform" rating and a $139.00 target price on the stock. Four analysts have rated the stock with a hold rating and eleven have given a buy rating to the company. Based on data from MarketBeat.com, Cardinal Health presently has a consensus rating of "Moderate Buy" and an average price target of $139.36.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.